Introduction
============

During vertebrate gastrulation, an embryo of simple and symmetrical morphology is reshaped to reveal its fundamental body plan. This process is accomplished by cooperation of four morphogenetic movements---epiboly, internalization, and convergence and extension (C&E)---that are largely conserved among vertebrates ([@bib3]; [@bib30]; [@bib44]). Epiboly starts at the late blastula stage as the yolk cell pushes into the blastoderm, which thins and expands vegetally until it encloses the entire yolk cell ([@bib57]; [@bib45]; [@bib40]). At this stage, the embryo is composed of four cell layers: the enveloping layer (EVL), deep cells, the yolk syncytial layer (YSL), and the yolk cell. The EVL is a superficial epithelial layer that covers a mass of deep cells, which give rise to embryonic tissues. The YSL is a shallow and superficial cytoplasmic layer within the yolk cell ([@bib46]; [@bib40]). Proper epiboly involves coordinated movements of all of these layers, and the underlying cellular and molecular mechanisms remain to be fully defined ([@bib45]; [@bib40]).

Recent studies indicate that E-cadherin--mediated cell--cell adhesion plays a critical role in zebrafish epiboly. In both E-cadherin mutant embryos and embryos injected with E-cadherin morpholino oligonucleotides (MOs) to block its translation, the epibolic movement of the deep cells is delayed or arrested at midgastrulation, although the YSL and EVL expand vegetally in a relatively normal fashion ([@bib5]; [@bib23]; [@bib33]; [@bib43]). This epibolic delay has been attributed to impaired radial intercalation resulting from decreased adhesion among the deep cells and between the deep cells and the EVL ([@bib23]; [@bib36]; [@bib43]). An additional cell--cell adhesion defect was observed in E-cadherin--deficient embryos, with cells bulging and detaching from the embryonic surface ([@bib5]; [@bib23]; [@bib33]; [@bib43]).

E-cadherin is a plasma membrane glycoprotein that is indirectly linked to the actin cytoskeleton through β-catenin ([@bib6]). The involvement of E-cadherin in morphogenesis and differentiation during the early development has been also demonstrated in many species including mouse, chick, and frog ([@bib17]). In addition, E-cadherin is essential for cell migration and polarity, as well as neuronal synapse function. E-cadherin expression is regulated at various levels including gene expression, protein stability, and intracellular protein distribution ([@bib17]). Down-regulation of E-cadherin is regarded as the hallmark of the epithelial--mesenchymal transition, and is often observed in invasive tumor cells ([@bib7]).

In comparison to our fairly detailed knowledge about the regulation of E-cadherin expression, we know very little about regulation of its activity. However, recent studies in cell culture indicate that heterotrimeric G proteins of the Gα~12~ family (Gα~12~ and Gα~13~) can modulate E-cadherin function: Gα~12/13~ can bind E-cadherin at its cytoplasmic domain to block the β-catenin--binding site, resulting in inhibition of cell--cell adhesion ([@bib25]; [@bib35]; [@bib34]). Nevertheless, the significance of the Gα~12/13~ and E-cadherin interaction during morphogenesis remains to be tested.

During epiboly, the yolk cell may serve as a towing motor to drive the movements of epiboly. Nuclei of the YSL move vegetally even after removal of the blastoderm ([@bib52]), which indicates that the YSL can undergo epiboly autonomously. Because the EVL and the YSL are tightly attached ([@bib8]), EVL epiboly is believed to depend on the YSL expansion. In addition, endocytosis in the YSL near the blastoderm margin results in removal of the yolk cytoplasmic membrane and could play a role in epiboly by drawing the blastoderm to the vegetal pole ([@bib54]; [@bib46]).

The cytoskeleton plays many important roles during epiboly. Extensive microtubule networks in the yolk cell may facilitate the epibolic movements, as microtubule disruption completely inhibits the movement of yolk syncytial nuclei (YSN) and impairs the epibolic movements of the deep cells and the EVL ([@bib48]; [@bib46]). A decrease in the amount of polymerized microtubules in the yolk cell also leads to epiboly delay ([@bib19]). Actin microfilaments throughout the embryo contribute to epiboly as well ([@bib60]; [@bib12]; [@bib27]). Three distinct actin structures are elaborated during late epiboly stages: two rings at the margin of the deep cells and the EVL, and a punctate band of actin accumulation in the external YSL adjacent to the EVL margin ([@bib12]). It has been proposed that the actin rings act as a "purse string" to pull the EVL vegetally, thereby advancing the epiboly process ([@bib12]), whereas the punctate band of contractile elements including actin and myosin 2 in the YSL contributes to the shortening of the actin bands and the EVL margin, moving the EVL toward the vegetal pole ([@bib27]). Disruption of these actin structures, as a consequence of either cytochalasin B treatment ([@bib12]), interference with myosin2 ([@bib27]), or the homeobox transcription factor Mtx2 ([@bib58]), results in a delay or failure in epiboly. Similarly, an abnormal cytoskeleton contributes to the epibolic delay in Pou5fl-deficient embryos ([@bib29]).

We previously demonstrated that Gα~12/13~ are required for C&E gastrulation movements in zebrafish ([@bib31]). Here, we find that Gα~12/13~ regulate epiboly in zebrafish, and provide evidence that Gα~12/13~ interact with E-cadherin to negatively modulate E-cadherin--mediated cell--cell adhesion. Moreover, we show that Gα~12/13~ also regulate epiboly by promoting actin microfilament assembly through a Rho guanine nucleotide exchange factor (GEF)-dependent signaling pathway. Our results therefore identify a novel Gα~12/13~-dependent mechanism for modulating epiboly during vertebrate gastrulation.

Results
=======

Disruption of Gα~12/13~ function results in epiboly delay
---------------------------------------------------------

We have previously identified one Gα~12~ and two Gα~13~ (Gα~13~a and Gα~13~b isoforms) in zebrafish and demonstrated that proper Gα~12/13~ signaling is essential for C&E movements, as well as for epiboly during zebrafish gastrulation ([@bib31]). To define further the mechanisms whereby Gα~12~ and Gα~13~ regulate epiboly, we used gain- and loss-of-function approaches. To enhance Gα~13~ function, we injected embryos with a synthetic RNA encoding Gα~13~a. To inhibit Gα~12/13~ function, we injected embryos with a mixture of antisense MOs (3MO) that interfere with translation of the three Gα~12/13~ transcripts (*gna13a*, *gna13b*, and *gna12*; 4 ng each). Alternatively, we injected a synthetic RNA encoding the carboxy-terminal (CT) peptides of Gα~12/13~, which have been shown to disrupt the coupling of Gα~12/13~ to their cognate receptors ([@bib1]; [@bib15]; [@bib2]; [@bib31]). In zebrafish, epiboly initiates at the sphere stage and is complete when the blastoderm encloses the yolk cell ([@bib57]). Embryos with either an excess or deficiency of Gα~12/13~ expression initiated epiboly and progressed through early stages at rates comparable to those of their uninjected siblings. Furthermore, they underwent internalization normally and formed embryonic shields of normal morphology (unpublished data). However, when the blastoderm covered 70% of the yolk cell in control embryos (70% E), embryos with altered Gα~12/13~ activity lagged in epibolic movements behind their siblings by 10--20%. By 80% E, only a very small fraction of uninjected embryos (1.1 ± 1.9%; 136 embryos) showed epiboly defects, yet a majority of embryos overexpressing Gα~13~a (98.5 ± 2.6%, 258 embryos), injected with the Gα~13~-CT RNA (86.5 ± 6.5%, 106 embryos) or injected with 3MO (84.4 ± 5.7%, 143 embryos), exhibited epiboly defects ([Fig. 1 M](#fig1){ref-type="fig"}).

![**Gα~12/13~ regulate epibolic movements of the deep cells.** (A and B) Nomarski images of control WT embryos (A) and embryos overexpressing Gα~13~a (B) at 80% epiboly (A′ and B′ are schematic drawings of A and B), showing the dcm and YSL nuclei (YSLn; green arrows and dots), which move together in control embryos (A and A′) but are separated in embryos overexpressing Gα~13~a (B and B′). (C and D) Nomarski images of yolk cell region at high magnification in a control WT embryo (C) and an embryo overexpressing Gα~13~a (D), showing distortions in the YCL (white arrowheads). (A--D) Lateral view, with dorsal shown toward the right and vegetal toward the bottom. (E--H) Nomarski images of control WT embryos (E), embryos overexpressing either full-length Gα~13~a (F), or the CT fragment of Gα~13~a (Gα~13~-CT; G), and embryos injected with 3MOs against *gna13a*, *gna13b*, and *gna12* (4 ng each; H) at 95% epiboly. (E′--H′) Schematic drawings of E--H. Vegetal view is shown. df, df cells (red arrowheads). Note: in F--H versus E, the vegetal opening is much larger, and dfs are separated from the dcm; in F and H, the dfs are split. (I--L) Expression of the *ntl* mRNA at 90% epiboly. Images show *ntl* expression domains at dcm and df. Dorsal view, with the vegetal pole (VP; blue lines) toward the bottom. Yellow lines with double arrows, distance from dcm to VP. Bars, 100 µm. (M) The percentage of embryos with epibolic defects. Data are compiled from two to three different experiments. Error bars represent mean ± SEM.](JCB_200805148_RGB_Fig1){#fig1}

The YSL consists of an internal YSL and an external YSL that is populated with YSN ([@bib46]). The EVL is tightly linked to the YSL margin. Therefore, as seen in [Fig. 1 (A and A′)](#fig1){ref-type="fig"}, during the course of normal epiboly, the YSN and the deep cell margin (dcm) stay together (the EVL is invisible, as it is not in the focal plane; [@bib53]; [@bib46]). However, in embryos overexpressing Gα~13~a, a sizable gap was formed between the YSN and the dcm ([Fig. 1, B and B′](#fig1){ref-type="fig"}), which indicates that epibolic movement of the deep cells lags behind the movement of the YSL. Thus, the distance between the dcm and the vegetal pole is significantly greater in embryos overexpressing Gα~13~a than in the uninjected control ([Fig. 1, A and B](#fig1){ref-type="fig"}). In addition, we noted that in contrast to the uniform and smooth appearance of the yolk cytoplasmic layer (YCL; a thin anuclear cytoplasmic layer covering the yolk mass) in control embryos ([Fig. 1 C](#fig1){ref-type="fig"}), this structure was frequently distorted in Gα~13~a-expressing embryos, exhibiting an uneven thickness ([Fig. 1 D](#fig1){ref-type="fig"}, arrowheads). As epiboly progressed to 95% E, the dcm of wild-type (WT) embryos moved closer to the vegetal pole ([Fig. 1, E and E′](#fig1){ref-type="fig"}), but those of embryos overexpressing Gα~13~a, the dominant-negative Gα~13~-CT peptide, or injected with 3MO had a much larger vegetal opening ([Fig. 1, E--H′](#fig1){ref-type="fig"}). Moreover, the dorsal forerunners (dfs), a small dorsal cell population that normally moves toward the vegetal pole as a single cluster in close association with the dcm ([Fig. 1 E](#fig1){ref-type="fig"}; [@bib13]), were well separated from the dcm and far ahead of the remaining deep cells in embryos with reduced or excess Gα~12/13~ function. Interestingly, in these embryos, the df cells split and formed several smaller clusters ([Fig. 1, F--H](#fig1){ref-type="fig"}). These observations in live embryos were confirmed by analyzing the expression of the *no tail* (*ntl*) gene, which marks the mesodermal precursors at the dcm and the df cells ([@bib42]). As seen in [Fig. 1 (I--L)](#fig1){ref-type="fig"}, the distance between the dcm and the vegetal pole was significantly greater in embryos with either reduced or excess Gα~12/13~ function than that in control embryos, and dfs were separated from the dcm and divided into several smaller clusters. The observed delay in epiboly and abnormal behavior of the dfs resemble aspects of the phenotypes that have been described for the *half-baked* (*hab*) mutants, which harbor mutations in the *cadherin1* (*cdh1*; E-cadherin) gene ([@bib22]; [@bib24]), and in embryos injected with an MO that targets *cdh1* ([@bib5]). This observation suggested a possible link between Gα~12/13~ function and E-cadherin activity.

In embryos overexpressing Gα~13~a, but not those injected with Gα~13~-CT RNA or 3MO (not depicted), cells frequently dissociated from the embryonic surface ([Fig. 2, A--C′](#fig2){ref-type="fig"}), and gaps formed between the paraxial and axial mesoderm during segmentation ([Fig. 2 E](#fig2){ref-type="fig"}). These phenotypic changes have also been observed in *hab* mutant embryos and have been attributed to defects in cell--cell adhesion ([@bib23]; [@bib33]). Together, these observations suggest that Gα~12/13~ signaling may negatively regulate E-cadherin--mediated cell--cell adhesion during zebrafish gastrulation.

![**Overexpression of Gα~13~a results in cell adhesion defects in embryonic tissues.** (A--C′) Nomarski images of uninjected WT embryos, embryos overexpressing Gα~13~a, and *hab^vu44/vu44^* mutant (E-cadherin--deficient) embryos. Higher magnification images of the boxed areas are shown in A′--C′. Red arrows indicate cells detaching from the blastoderm. Lateral view is shown, with dorsal (D) toward the right and the vegetal pole (VP) toward the bottom. (D and E) Nomarski images of notochord and somites in the WT embryos and embryos overexpressing Gα~13~a at the 4--5 somite stage. Red arrowheads indicate gaps between the notochord and somites. Dorsal view is shown, with anterior to the left. Bars, 100 µm.](JCB_200805148R_RGB_Fig2){#fig2}

Gα~12/13~ do not influence E-cadherin expression or intracellular distribution
------------------------------------------------------------------------------

To test the hypothesis that Gα~12/13~ regulate epiboly by modulating the function of E-cadherin, we first determined if Gα~12/13~ affect the expression of E-cadherin in embryos with reduced or excess signaling. We performed Western blot analyses using an anti--E-cadherin antibody with protein extracts prepared either from gastrulae injected with *gna13a* RNA or 3MO, or from uninjected control siblings. As shown in [Fig. 3 A](#fig3){ref-type="fig"}, two prominent bands of E-cadherin, which may correspond to two glycosylation forms of E-cadherin, were detected, as described previously ([@bib5]). There was no clear difference in the expression level of E-cadherin protein between the control embryos and embryos with excess or reduced Gα~12/13~ signaling ([Fig. 3 A](#fig3){ref-type="fig"}). We then performed whole-mount immunostaining to determine if Gα~12/13~ regulate the cellular distribution of E-cadherin. It has been shown that E-cadherin is expressed at a higher level at the anterior region of the hypoblast during gastrulation ([@bib5]). To identify this region, we used embryos obtained from transgenic *TG*:\[*gsc-GFP*\] fish, in which GFP is expressed in the dorsal midline ([@bib14]; [@bib20]). As shown in [Fig. 3 B](#fig3){ref-type="fig"}, in control embryos at 70% E, E-cadherin was expressed in all blastomeres, predominantly on the cell membranes, but also in a punctate pattern in the cytosol, as described previously ([@bib5]; [@bib36]). Our analyses revealed that neither Gα~13~a overexpression nor Gα~12/13~ down-regulation (3MO-mediated) affected the expression level or the cellular distribution of E-cadherin ([Fig. 3 B](#fig3){ref-type="fig"}).

![**Altered Gα~12/13~ expression does not change the levels and distribution of E-cadherin and β-catenin.** (A) Western blots showing the expression levels of E-cadherin, the G protein β subunit, and β-catenin in the uninjected WT, Gα~13~a-overexpressing, and three MOs (3MO)-injected gastrulae. (B and C) Confocal images showing the cellular distribution of E-cadherin (red) in the anterior mesendoderm of embryos at 70% E (B; *gsc*-GFP labels the prechordal mesoderm), and of β-catenin in the lateral mesoderm in embryos at 80% E (C). Bars, 10 µm.](JCB_200805148_RGB_Fig3){#fig3}

Gα~12/13~ regulate epiboly by inhibiting E-cadherin activity
------------------------------------------------------------

Next, we aimed to determine whether Gα~12/13~ modulate E-cadherin function in vivo by testing their genetic interactions. We took advantage of a zebrafish mutant, *hab^vu44^*, harboring a premature stop codon at amino acid residue L553 within the EC4 domain of the extracellular portion of the *cdh1* gene ([@bib23]). *hab^vu44/vu44^* embryos display an epiboly delay/arrest after midgastrulation, probably due to a moderating effect of the maternal contribution of E-cadherin, which has been shown to cooperate with the zygotically expressed E-cadherin to regulate epiboly ([@bib43]). We injected embryos derived from crosses among *hab^vu44^* heterozygous fish with either a small dose of synthetic RNA encoding Gα~13~a (10 pg) or a single MO against Gα~13~a or Gα~12~ (4 ng) to elevate or reduce the function of Gα~13~ or Gα~12~, respectively. Such treatments alone had no effect on the epiboly in WT embryos (unpublished data). We then assessed whether this manipulation of Gα~12/13~ function can modulate the phenotypic changes caused by E-cadherin deficiency by analyzing the *ntl* expression profile. We reasoned that if Gα~12/13~ negatively regulate the E-cadherin activity, then excess Gα~12/13~ function exacerbates it, and decreased Gα~12/13~ signaling should suppress the phenotypic changes caused by E-cadherin deficiency. Among the uninjected progeny from *hab*^*vu44*/+^ parents, 63 ± 11% embryos showed a normal pattern of *ntl* expression ([Fig. 4 A](#fig4){ref-type="fig"}); 16 ± 9% exhibited mild defects in epiboly, in which their df cells were divided into smaller clusters in spite of being tightly associated with the margin (type I defect; [Fig. 4 B](#fig4){ref-type="fig"}); and 20 ± 3.3% showed a strong epiboly delay in the deep cells and obvious separation of the df cells from the dcm (type II defect; [Fig. 4 C](#fig4){ref-type="fig"}). This phenotypic distribution is consistent with a partial penetrance of both the dominant df defect and the recessive epiboly phenotype of *hab^vu44^* mutation ([@bib23]). A reduction in the expression of either Gα~12~ or Gα~13~ in the progeny of *hab*^*vu44*/+^ heterozygotes partially suppressed the mutant epibolic defects, as indicated by a significant increase in the proportion of embryos showing normal *ntl* expression in the blastoderm margin and df cells, and a decrease in the percentage of embryos with severe epibolic defects (type II; [Fig. 4 E](#fig4){ref-type="fig"}). Conversely, a slight increase in Gα~13~ activity exacerbated these defects ([Fig. 4, D--E](#fig4){ref-type="fig"}). These results support the notion that Gα~12/13~ regulate epiboly through E-cadherin by acting as negative regulators of E-cadherin activity.

![**Gα~12/13~ signaling modulates the phenotype of *hab^vu44^* mutant embryos.** (A--C) Different phenotypic classes of progeny of *hab^vu44/+^* parents revealed by *ntl* staining: normal pattern (A), type I (B), and type II (C). See text for details. (D) A representative image showing exacerbation of epibolic defects of *hab^vu44^* mutant embryos overexpressing Gα~13~a (20 pg; see text for details). A dorsal view is shown. AP, animal pole; VP, vegetal pole. Bars, 100 µm. (E) Effects of altered Gα~12/13~ signaling on distribution of the phenotypic classes of progeny from *hab^vu44/+^* parents. The data were generated from at least three separate experiments, with the total number of embryos indicated below the graph. Error bars represent mean ± SEM. \*, P \< 0.001; \*\*, P \< 0.05; †, P \< 0.01; \#, P \< 0.001 versus control.](JCB_200805148_RGB_Fig4){#fig4}

Gα~12/13~ interact with E-cadherin and inhibit cell adhesion
------------------------------------------------------------

To better understand the mechanisms by which Gα~12/13~ regulate E-cadherin activity, we set out to test these two proteins for physical interactions in vivo. Because previous studies in cultured cells had shown that mammalian Gα~12~ or Gα~13~ can bind the cytoplasmic domain of E-cadherin ([@bib25]; [@bib35]), we performed the following procedures. First, we cotransfected HEK 293 cells with zebrafish Gα~13~a and a GST-tagged construct encoding the E-cadherin cytoplasmic terminus (E-cad--CyT) or GST only, and performed a GST pull-down assay. As shown in [Fig. 5 A](#fig5){ref-type="fig"}, Gα~13~a was pulled down by GST--E-cad--CyT but not by GST alone, which suggests a specific association between zebrafish Gα~13~a and the E-cad--CyT. In addition, we demonstrated that β-catenin can compete with Gα~13~a for the binding to E-cadherin in a dose-dependent manner ([Fig. 5 B](#fig5){ref-type="fig"}), confirming that the β-catenin-- and Gα~13~a-binding sites on E-cadherin are close to one another ([@bib25]). However, we did not observe any obvious change in the expression level and intracellular distribution of β-catenin in embryos with altered Gα~12/13~ expression ([Figs. 3 C](#fig3){ref-type="fig"} and [S1](http://www.jcb.org/cgi/content/full/jcb.200805148/DC1)).

![**Gα~13~a interacts with E-cadherin and inhibits cell adhesion.** (A) Gα~13~a interacts with the cytoplasmic domain of E-cadherin. The GST pull-down assay was performed on cell extracts from HEK 293 cells cotransfected with Gα~13~a and either GST or a GST-tagged cytoplasmic domain of E-cadherin (GST--E-cad--CyT). The precipitates were immunoblotted with anti-Gα~13~ and anti-GST antibodies. The level of Gα~13~a expression in the lysates is shown at the bottom of the panel. (B) β-catenin competes with E-cadherin for binding to Gα~13~a in a dose-dependent manner. HEK 293 cells were transfected with Gα~13~a and GST--E-cad--CyT with or without β-catenin at various doses, and the GST pull-down assay was performed. The expression levels of β-catenin and Gα~13~a in the lysates are shown. (C and D) Overexpression of Gα~13~a enhances cell scattering in the blastoderm. Shown are representative images of labeled cells in the blastoderm of control WT embryos and embryos overexpressing Gα~13~a scattering over time. The area of cell scattering is indicated by the yellow broken lines, which mark the cells at the outer edge. Bars, 100 µm. (E) Quantitative data from four separate experiments (eight embryos in each group), showing the ratio of the area of cell scattering relative to the starting point, at different time points. Error bars represent mean ± SEM. \*, P \< 0.05 versus control.](JCB_200805148R_RGB_Fig5){#fig5}

E-cadherin is known to regulate cell--cell adhesion in zebrafish ([@bib34]; [@bib36]) and many other animals ([@bib17]). Moreover, the binding of Gα~13~ to E-cadherin interferes with its cell adhesive function in mammalian cultured cells ([@bib34]). To determine if Gα~12/13~ can influence cell adhesion in zebrafish, we performed a cell tracing experiment in embryos ([@bib56]). In this assay, zygotes were first injected with *gna13a* RNA to enhance Gα~13~ function. At the 256-cell stage, a single cell at the animal pole of an uninjected or *gna13a*-RNA--injected blastula was then injected with fluorescein dextran, then the distribution of the progeny of the labeled cells at several time points up to 50%E was analyzed. During embryonic development, blastomeres at the animal pole become separated from each other by intercalating radially from deeper layers to the more superficial layers without significant directional migration ([@bib57]). This phenomenon is thought to be mediated by E-cadherin--dependent cell--cell adhesion interactions, because in *hab* mutants (E-cadherin deficient), cells intercalate from the deeper to the more superficial layers but fail to maintain this position and often fall back into the deeper layer ([@bib56]; [@bib23]). We found that progeny of the labeled cells gradually dispersed over time in control embryos ([Fig. 5 C](#fig5){ref-type="fig"}) and in embryos overexpressing Gα~13~a ([Fig. 5 D](#fig5){ref-type="fig"}). To quantify the scattering, we marked the outside edge of the regions containing the labeled cells, and calculated the areas. We then determined a scattering factor by comparing the areas at different time points to the initial area for each embryo. 1 h after injection, the scattering factor for the Gα~13~a-expressing embryos was similar to that of control embryos. However, by the second and third hour, the ratio in embryos overexpressing Gα~13~a was significantly greater than that in control embryos ([Fig. 5, C--E](#fig5){ref-type="fig"}). These results indicate that overexpression of Gα~13~a enhanced dispersion in the blastoderm during epiboly, which suggests that Gα~13~a-expressing cells have a reduced tendency to adhere to one another. These findings provide further support for the notion that signaling via Gα~13~ negatively regulates E-cadherin activity.

Gα~12/13~ regulate actin cytoskeleton assembly during epiboly via a RhoGEF/Rho-dependent pathway
------------------------------------------------------------------------------------------------

Although embryos with enhanced or decreased Gα~12/13~ showed similar epibolic defects in deep cells as E-cadherin mutant embryos, we noted that Gα~13~a-overexpressing embryos exhibited additional defects such as a distorted YCL ([Fig. 1 D](#fig1){ref-type="fig"}), which suggests that Gα~13~a signaling may contribute to the regulation of epiboly via additional mechanisms that are independent of E-cadherin. Such distortions of the YCL have also been observed in embryos with cytoskeleton abnormalities; e.g., in embryos treated with taxol to stabilize microtubules ([@bib46]) or in Pou5fl mutants ([@bib29]). We have previously shown that, like their mammalian counterparts, zebrafish Gα~12/13~ can promote actin stress fiber formation in cultured cells ([@bib31]). Based on these observations, we tested whether Gα~12/13~ can also regulate cytoskeletal function in zebrafish gastrulae.

To assess the organization of actin cytoskeleton during gastrulation, we visualized actin by whole-mount immunostaining with phalloidin. As shown in [Fig. 6 (A--D)](#fig6){ref-type="fig"}, the confocal images revealed the periphery of the superficial EVL cells and the deep cells beneath, as well as two actin rings at the margins of the deep cells and the EVL ([Fig. 6, A--D](#fig6){ref-type="fig"}, red and green arrowheads, respectively), as reported previously ([@bib12]). In WT embryos, the actin rings adjacent to the deep cells and the EVL are closely associated ([Fig. 6 A](#fig6){ref-type="fig"}), which indicates that EVL and the deep cells move together toward the vegetal pole during epiboly. Consistent with previous papers on studies performed in *hab^vu44/vu44^* mutant embryos, the deep cells exhibited impaired epiboly and lagged behind the EVL margin ([Fig. 6 D](#fig6){ref-type="fig"}); whereas the EVL underwent epiboly at a relatively normal rate, as revealed by the observation that the distance between the EVL margin and the vegetal pole ([Fig. 6](#fig6){ref-type="fig"}, yellow lines with arrows) in the mutant was comparable to that in WT embryos ([Fig. 6, A and D](#fig6){ref-type="fig"}; [@bib23]; [@bib27]). As expected, embryos with reduced or excess Gα~12/13~ function displayed similar epibolic defects of the deep cells (separation from EVL margin), although the defects were more minor than those in *hab^vu44/vu44^* mutant embryos ([Fig. 6, B--D](#fig6){ref-type="fig"}). However, embryos with altered Gα~12/13~ function exhibited an epibolic delay of the EVL, as the distance between the EVL margin and vegetal pole ([Fig. 6](#fig6){ref-type="fig"}, yellow lines with arrows) was significantly increased relative to that in the age-matched uninjected WT embryos ([Fig. 6, A--C](#fig6){ref-type="fig"}).

![**Gα~12/13~ regulate cytoskeleton organization during epiboly.** (A--D) Confocal images show phalloidin staining of F-actin in gastrulae. Red and green arrowheads indicate the margin of the deep cells and the EVL, respectively; yellow lines with arrows indicate the distance between the EVL margin and the vegetal pole (VP; white lines). Pink asterisks indicate the actin bundles in the yolk. (E--G) Representative images of the EVL cells indicated at high magnification. The cell boundaries of a few EVL cells of each group are highlighted. Note: the EVL cells in embryos injected with 3MO and embryos overexpressing Gα~13~a are rounder and not correctly aligned. Yellow arrows indicate an actin ring in the vegetal margin of the EVL. Bars, 100 µm. (H) Quantitative data showing the LWRs of the EVL cells close to the margin. Error bars represent mean ± SEM. \*, P \< 0.05 versus WT. \#, P \> 0.05 versus control. (I--K) The half-Rose diagrams show the numbers of EVL cells for which the angle of the long axis relative to a line parallel to the EVL margin falls within each sector.](JCB_200805148_RGB_Fig6){#fig6}

During epiboly, the constriction of the marginal EVL cells leads to dramatic cell-shape changes in the EVL cells, and to the elongation of the EVL cells along the animal--vegetal axis. Failure of such cell-shape changes has been implicated in epibolic defects ([@bib27]). To further evaluate the morphology of the EVL cells in embryos with altered Gα~12/13~ function, we took confocal images of phalloidin-stained embryos at higher magnification, and analyzed cell shape (length-to-width ratio \[LWR\]) and orientation (the angle of the long axis of the EVL cells relative to a line parallel to the EVL margin) of the EVL cells near the margin. As shown in [Fig. 6 (E--H)](#fig6){ref-type="fig"}, there was no significant difference in the intensity of F-actin staining in the EVL cells between the uninjected WT embryos and embryos injected with 3MO or the Gα~13~a RNA. However, both the shape and orientation of the EVL cells in embryos with reduced or excess Gα~12/13~ function were significantly altered with respect to those in the control embryos ([Fig. 6 E-G](#fig6){ref-type="fig"}). In the uninjected control embryos, the EVL cells were elongated, with a mean LWR of 1.73 ± 0.3 (220 cells, 6 embryos), and were orientated at an angle of 67 ± 20°. Of 220 cells counted, 73% aligned their cell bodies at an angle in the range of 60--120° with respect to the EVL margin; this indicates that most of these cells elongate vegetally along a line roughly perpendicular to the EVL margin, which is consistent with the direction of the epibolic movement. Similarly, the EVL cells in *hab^vu44/vu44^* mutant embryos were elongated and aligned properly (LWR = 1.79 ± 0.54; angle = 64 ± 16°C; 171 cells, 3 embryos; P \> 0.05 vs. WT). In contrast, in embryos with reduced or excess Gα~12/13~ function, the EVL cells were significant rounder (smaller LWR; 3MO: LWR = 1.46 ± 0.32, 379 cells, 8 embryos; Gα~13~a: LWR = 1.55 ± 0.44, 342 cells, 8 embryos; P \< 0.001 vs. control; [Fig. 6, E--H](#fig6){ref-type="fig"}). In addition, these EVL cells were more disorganized and failed to align their cell bodies along the direction of epibolic movement, with orientations of 52 ± 26° or 54 ± 25° (P \< 0.001 vs. control) in Gα~12/13~-depleted or Gα~13~a-overexpressing embryos, respectively. Moreover, only 41--49% of the cells from these embryos exhibited an angle within the range of 60--120°, which suggests that most EVL cells in these embryos were oriented in random directions ([Fig. 6, E--G and I--K](#fig6){ref-type="fig"}). Interestingly, the punctate actin accumulation adjacent to the EVL margin was markedly reduced in embryos overexpressing Gα~13~a ([Fig. 6 G](#fig6){ref-type="fig"}; compare the yellow arrows [Fig. 6, E and G](#fig6){ref-type="fig"}). Moreover, these embryos exhibited abnormal formation of actin bundles in the YCL, although these are rarely observed in the yolk cells of WT embryos. This is possibly due to the aggregation or contraction of F-actin, which was absent in some areas of the cortical cytoplasmic layer ([Fig. 6, C and G](#fig6){ref-type="fig"}).

Work in mammalian systems has established that Gα~12/13~ regulate actin cytoskeleton dynamics to modulate cell shape and migration via a RhoGEF/Rho-dependent signaling pathway ([@bib9]; [@bib16]; [@bib18]; [@bib28]). We have shown previously that, like zebrafish Gα~12/13~, one of the zebrafish RhoGEFs, PDZRhoGEF (Arhgef11), can induce stress fiber formation in HEK 293 cells ([@bib31]; [@bib37]), which suggests that zebrafish Gα~12/13~ also function through RhoGEF to regulate actin organization. Furthermore, we showed that, when coexpressed in HEK 293 cells, Gα~13~a specifically coprecipitated with myc-tagged full-length Arhgef11, and this interaction was not observed when an Arhgef11 mutant lacking the RGS domain, known to be required for target binding, was coexpressed. This indicates that Gα~12/13~ physically interact with PDZRhoGEF via the RGS domain ([Fig. 7 J](#fig7){ref-type="fig"}).

![**Gα~13~a promotes actin assembly via a PDZ RhoGEF-dependent pathway.** (A--D) Nomarski images of live WT embryos (A), embryos overexpressing Gα~13~a alone (B), embryos overexpressing Gα~13~a and a dominant-negative mutant zebrafish Arhgef11, ΔDHPH (C), or embryos overexpressing Arhgef11 (D) at 80% epiboly. Bar, 250 µm. (E--H) Confocal z-projection images show phalloidin staining of F-actin. Red and green arrowheads indicate the dcm and the EVL, respectively; pink asterisks show the actin bundles in the yolk. Note the gap between dcm and the EVL, and the lack of actin bundles in embryos coinjected with Gα~13~a and a ΔDHPH-encoding RNA. VP, vegetal pole. Bars, 100 µm. (I) The percentage of embryos with actin bundles in the embryos expressing Gα~13~a alone or both Gα~13~a and ΔDHPH. \*, P \< 0.05 versus Gα~13~a. (J) Gα~13~a interacts with zebrafish Arhgef11. Coimmunoprecipitation was performed on cell extracts from HEK 293 cells transfected with Gα~13~a or Arhfef11 alone, or with both Gα~13~a and myc-tagged Arhgef11 forms (WT, dominant-negative mutants lacking the RGS domain \[ΔRGS\], or lacking the DH and PH domains \[ΔDHPH\]). Immunoblotting was performed with the indicated antibodies. Error bars represent mean ± SEM.](JCB_200805148_RGB_Fig7){#fig7}

To determine if zebrafish Gα~12/13~ modulate epiboly via a RhoGEF-dependent signaling pathway, we first examined the effect of Arhgef11 overexpression on epiboly. The overexpression of Arhgef11 resulted in similar epiboly defects and distortions in the YCL, similar to those observed for Gα~12/13~ overexpression ([Fig. 7 D](#fig7){ref-type="fig"} and not depicted). Actin staining revealed that embryos overexpressing Arhgef11 also exhibited delayed epiboly of the deep cells and the EVL as well as the formation of thick actin bundles in the YCL ([Fig. 7 H](#fig7){ref-type="fig"}). Similar defects were observed in embryos overexpressing a constitutively activated zebrafish RhoA (data not shown). To test whether RhoGEF acts downstream of Gα~12/13~ in the regulation of the actin cytoskeleton, we coexpressed Gα~13~a together with a dominant-negative form of Arhgef11 lacking the DH and PH domains (ΔDHPH), which are needed for interacting with downstream proteins ([@bib37]). We found that Arhgef11 ΔDHPH bound to Gα~13~ ([Fig. 7 J](#fig7){ref-type="fig"}) and suppressed both the formation of actin bundles in the YCL and the epiboly defects associated with Gα~13~a overexpression ([Figs. 1 M](#fig1){ref-type="fig"} and [7](#fig7){ref-type="fig"}). Although actin bundles were found in 86 ± 5% of the embryos overexpressing Gα~13~a, only 33 ± 3% of the embryos coexpressing Gα~13~a and Arhgef11 ΔDHPH showed this phenotype ([Fig. 7 I](#fig7){ref-type="fig"}). However, we observed that coexpression of Arhgef11 ΔDHPH did not fully rescue the epibolic delay in the deep cells ([Fig. 7 G](#fig7){ref-type="fig"}), which suggests that cytoskeletal assembly regulated by Arhgef11 only partially accounts for the function of Gα~12/13~ in epiboly. Collectively, these results indicate that Gα~12/13~ can regulate epiboly through a PDZ RhoGEF/RhoA-dependent signaling pathway to modulate the function of the actin cytoskeleton.

Discussion
==========

In this paper, we demonstrate that Gα~12/13~ signaling can regulate different aspects of epiboly movements by two distinct mechanisms: inhibiting E-cadherin activity and modulating actin cytoskeleton organization.

Excess or reduced Gα~12/13~ signaling during gastrulation resulted in delayed epiboly of the deep cells and in the splitting of the df cell cluster ([Fig. 1](#fig1){ref-type="fig"}). Moreover, excess Gα~12/13~ activity led to the detachment of cells from embryonic tissues, which suggests that cell adhesion is defective under these circumstances ([Fig. 2](#fig2){ref-type="fig"}). All of these phenotypic characteristics resemble those observed in *hab* (*cdh1*) mutant embryos ([@bib22]; [@bib24]), which suggests a possible link between Gα~12/13~ signaling and E-cadherin. Indeed, although altered Gα~12/13~ expression did not change the expression level and cellular distribution of E-cadherin ([Fig. 3](#fig3){ref-type="fig"}), our in vivo genetic experiments demonstrated that Gα~12/13~ can inhibit the function of E-cadherin. In particular, we found that a reduction in the expression of either Gα~12~ or Gα~13~ function by MO injection partially suppressed, whereas an increase in Gα~13~ activity exacerbated the epibolic defects in *hab* mutant mutants ([Fig. 4](#fig4){ref-type="fig"}). Interestingly, decreased Gα~12/13~ function reduced the fraction of embryos with a weak epibolic defect, as well as the fraction with a strong epibolic delay ([Fig. 4](#fig4){ref-type="fig"}). This suggests that reduced Gα~12/13~ function may suppress not only the epibolic defects in heterozygous embryos, but also those in homozygous mutants. We speculate that such an effect might be caused by the reduced inhibition of the maternal E-cadherin protein by Gα~12/13~ in homozygous mutants ([@bib5]; [@bib23]).

Our biochemical studies support the notion that Gα~12/13~ can interact with E-cadherin. We showed that zebrafish Gα~13~a was pulled down with the CT fragment of zebrafish E-cadherin (E-cad--CyT) in HEK cells ([Fig. 4](#fig4){ref-type="fig"}), which is consistent with the physical interaction between mammalian Gα~12/13~ and E-cadherin shown previously ([@bib25]; [@bib35]). The E-cad--CyT has been shown to act as a dominant-negative protein ([@bib41]). Accordingly, we observed that embryos expressing this fragment exhibited cleavage defects, and the detachment of blastodermal cells during early development and coinjection of Gα~13~a-RNA exacerbated these phenotypes (unpublished data). The region of E-cadherin that binds Gα~12/13~ was found to be located near the binding site for β-catenin ([@bib25]). This is supported by our result showing that β-catenin can compete with Gα~13~ for E-cadherin binding in HEK cells ([Fig. 5 B](#fig5){ref-type="fig"}). Furthermore, it has been hypothesized that the binding of Gα~12/13~ to E-cadherin interferes with the ability of E-cadherin to form a complex with β-catenin. In fact, Gα~12/13~ overexpression can cause β-catenin to dissociate from E-cadherin and to translocate from the membrane to the cytosol in cultured cells ([@bib35]). We speculate that the competition of Gα~12/13~ with β-catenin for binding to E-cadherin may be one of the underlying mechanisms in embryos. However, we did not observe any overt change in expression level or intracellular distribution of β-catenin in embryos overexpressing Gα~13~a ([Fig. 3](#fig3){ref-type="fig"}). The reason for this discrepancy between studies in cell culture and our studies in zebrafish embryos is unclear. However, one possibility is that the levels of Gα~12/13~ we used were sufficient to alter E-cadherin activity but not to produce detectable changes in β-catenin distribution.

Studies from *hab* mutant embryos indicate that E-cadherin regulates epiboly in part by impinging on cell--cell adhesion ([@bib57]; [@bib36]; [@bib43]). Considering these findings in the light of our biochemical and genetic data showing that Gα~12/13~ functionally interact with E-cadherin in zebrafish, we propose that Gα~12/13~ modulate epibolic movement by inhibiting E-cadherin--mediated cell--cell adhesion. Accordingly, cells in embryos overexpressing Gα~13~a during early epiboly scattered across a larger area ([Fig. 5](#fig5){ref-type="fig"}). In addition, we also demonstrated that a larger scattering area in embryos overexpressing Gα~13~a is not due to an increase in cell number ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200805148/DC1)). However, we cannot rule out the possibility that other functions of Gα~12/13~ could contribute to reduced cohesion or abnormal cell movements.

In addition to the impaired epiboly of the deep cells, altered Gα~12/13~ signaling resulted in epibolic defects of the EVL ([Fig. 6](#fig6){ref-type="fig"}). This is in contrast to *hab^vu44^* and maternal-zygotic *cdh1^rk3^* mutant embryos, in which the EVL appears to undergo normal epiboly in spite of the fact that the deep cells exhibit severe epibolic defects ([Fig. 6 D](#fig6){ref-type="fig"}; [@bib43]). These results suggest that Gα~12/13~ may impinge on pathways other than the E-cadherin pathway to regulate epiboly in EVL cells. Recent evidence indicates that proper organization of the F-actin--based cytoskeleton plays critical roles in the normal epiboly of zebrafish embryos ([@bib60]; [@bib12]; [@bib27]). The actin contractile elements in the YSL are necessary for facilitating the proper EVL cell shape changes during late gastrulation ([@bib27]). Notably, in E-cadherin--deficient embryos, actin organization appeared to be normal, and EVL cells were elongated and orientated properly ([Fig. 6, D and H](#fig6){ref-type="fig"}; [@bib43]), which indicates that E-cadherin does not play a significant role in actin organization and EVL epiboly in zebrafish.

In mammalian cultured cells, Gα~12/13~ are known to be involved in the regulation of actin polymerization and the maintenance of proper cell morphology, which suggests that Gα~12/13~ may affect EVL epiboly by regulating actin cytoskeleton organization and/or function. Although there is no significant change in the organization of filamentous actin of EVL cells in embryos with altered Gα~12/13~ signaling, these cells displayed defects in cell shape and orientation ([Fig. 6](#fig6){ref-type="fig"}), which may contribute to the epibolic defects of the EVL. In addition, in embryos with excess Gα~12/13~ signaling, the punctate F-actin ring adjacent to the EVL was significantly reduced ([Fig. 6 G](#fig6){ref-type="fig"}), and abnormal thick actin bundles, separated by F-actin--free regions, were frequently found in the yolk ([Fig. 6, C and G](#fig6){ref-type="fig"}). We speculate that the thick actin bundles may cause abnormal "contractile" forces that disrupt the YCL; alternatively, these forces may create resistance to vegetal pulling of the EVL. Altogether, the changes in actin architecture resulting from altered Gα~12/13~ activities could prevent the EVL from undergoing active cell rearrangement and shape changes, ultimately affecting normal EVL epiboly. In E-cadherin mutants, in contrast, the abnormal actin fibers are not observed, and thus they are unlikely to be caused by a decrease in E-cadherin function. Interestingly, although the deep cells in embryos with altered Gα~12/13~ signaling displayed severe defects in epiboly, they did not exhibit corresponding changes in F-actin organization and cell shape (unpublished data). This further underscores the notion that epiboly of the deep cells might involve distinct mechanisms. However, we cannot exclude the possibility that in the deep cells, Gα~12/13~ also influence epiboly by modulating the actin cytoskeleton. Indeed, in differentiated leukocyte-HL60, Gα~12/13~ were shown to influence the actomyosin network during retraction of the trailing edge ([@bib59]). It will be interesting in the future to investigate how cell migration contributes to epiboly in zebrafish. Furthermore, in *Xenopus laevis*, it has been shown that two G protein--coupled receptors (GPCRs; the phospholipid lysophosphatidic acid \[LPA\] receptor and Xflop) that couple to Gα~12/13~ in some cell types ([@bib21]) can regulate expression of a calcium-dependent EP-cadherin and modulate the assembly of cortical actin ([@bib32]; [@bib49], [@bib50]). Therefore, it will be important in the future to investigate if LPA functions in a similar manner in zebrafish.

In addition, we found that embryos overexpressing Gα~13~ exhibited microtubule organization defects similar to those observed for F-actin, showing thick bundles of microtubules surrounded by areas devoid of microtubules ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.200805148/DC1)). However, embryos with reduced Gα~12/13~ do not show significant defects in microtubule organization (unpublished data), which suggests that at their normal expression levels, Gα~12/13~ do not play an essential role in microtubule stabilization in zebrafish.

Gα~12/13~ are known to regulate cytoskeletal function via a Rho-dependent signaling cascade. Several observations indicate that Gα~12/13~ appear to operate through the same signaling pathway to regulate actin organization during EVL epiboly. First, coexpression of a dominant-negative zebrafish PDZ RhoGEF, Arhgef11, with Gα~13~ significantly reduced the formation of actin bundles, and suppressed the epiboly defects in the EVL ([Figs. 1 M](#fig1){ref-type="fig"} and [7](#fig7){ref-type="fig"}). Conversely, overexpression of Arhgef11 or a constitutively active RhoA resulted in similarly abnormal actin organization in the yolk, and impaired epiboly ([Fig. 7, D and H](#fig7){ref-type="fig"}; and unpublished data). Notably, embryos expressing Arhgef11 did not exhibit the detachment of cells from the embryo surface (unpublished data), and Arhgef11 LOF did not result in obvious epiboly and C&E defects but gave rise to defects associated with ciliated epithelia ([@bib37]). We speculate that Arhgef11 and Gα~12/13~ may act in both overlapping and different signaling pathways during gastrulation. These results further support the idea that Gα~12/13~ regulate actin organization and cell adhesion via distinct mechanisms.

In summary, our studies establish Gα~12/13~ as novel regulators of epiboly in zebrafish. Our data indicate that Gα~12/13~ may regulate different aspects of epibolic movements by two distinct pathways. In the deep cells, Gα~12/13~ bind the intracellular domain of E-cadherin and inhibit its activity to modulate epiboly; in the EVL and the yolk cell, Gα~12/13~ promote actin cytoskeleton assembly through RhoGEF/RhoA in order to regulate epibolic movement of the EVL. It has been shown that Gα~12/13~ can transmit signals from different GPCRs and suggested that different GPCRs may activate distinct signaling pathways through Gα~12/13~ ([@bib39]). It will be interesting to determine if zebrafish epiboly involves different extracellular signals acting through distinct GPCRs via Gα~12/13~ to specify distinct cell behaviors in different cell types. Gα~12/13~ are oncogenes with transforming potential and growth-promoting activity ([@bib10]; [@bib55]; [@bib38]). Furthermore, the down-regulation of E-cadherin is associated with tumor metastasis and cancer progression ([@bib7]). Thus, our findings on the in vivo role of Gα~12/13~ in epiboly may have significant implications for the mechanisms whereby Gα~12/13~ function during tumorigenesis and metastasis, as well as during other morphogenetic processes in multicellular systems.

Materials and methods
=====================

Zebrafish strain and maintenance
--------------------------------

WT, transgenic *Tg*\[*gsc:GFP*\] ([@bib14]), and *hab^vu44^* mutant strains of zebrafish were maintained as described previously ([@bib47]). Embryos were obtained by natural mating and staged according to morphology as described previously ([@bib26]).

Generation of a GST-tagged cytoplasmic fragment of E-cadherin
-------------------------------------------------------------

The cytoplasmic domain of zebrafish E-cadherin (708-864AA) was cloned by PCR using the *cdh1* cDNA as a template ([@bib4]). The GST sequence was inserted in front of the 5′ end of the fragment, and the construct was verified by sequencing and by its expression (as ascertained by immunostaining with anti-GST antibody).

mRNA and antisense MO injections, in situ hybridization
-------------------------------------------------------

Capped sense mRNAs were synthesized using the SP6 mMessage machine (Applied Biosystems). The injection of synthetic mRNAs encoding Gα~13~a (60 pg), Gα~13~-CT (800 pg), myc-tagged PDZ RhoGEF (Arhgef11, 2pg), the dominant-negative mutant Arhgef11 (ΔDHPH, 600 pg), constitutively activated RhoA (10 pg), and antisense MOs targeting zebrafish *gna12*, *gna13a*, and *gna13b* transcripts (4 ng each) has been described previously ([@bib31]). Whole-mount in situ hybridization using an antisense *ntl* RNA probe was performed as described previously ([@bib51]), except that BM Purple (Roche) was used for the chromogenic reaction.

Western blotting
----------------

Embryos at 80% epiboly stage were manually deyolked and homogenized in lysis buffer ([@bib11]) to prepare embryo extracts. Equal amounts of protein were used for Western blot analysis. The following primary antibodies were used: anti--E-cadherin antibody (1:10,000; [@bib5]), anti-Gβ antibody (1:5,000; Santa Cruz Biotechnology, Inc.), and anti--β-catenin antibody (1:250; Sigma-Aldrich).

GST pull-down and coimmunoprecipitation assays
----------------------------------------------

HEK 293 cells were transiently cotransfected with cDNAs encoding Gα~13~a and GST or the GST-tagged CT fragment of E-cadherin; or zebrafish Gα~13~a and a myc-tagged full-length Arhgef11, or myc-tagged Arhgef11 mutants lacking the RGS domain (ΔRGS) or DH and PH domains (ΔDHPH; [@bib37]). After serum starvation overnight, cells were washed twice with serum-free medium and lysed in PBS containing 1% Igapal, 0.2% deoxycholate, and protease inhibitors. For the GST pull-down assay, protein extracts were incubated with glutathione--Sepharose beads (GE Healthcare). The presence of Gα~13~a in the lysates and precipitate was detected by anti-Gα~13~ antibody (1:1,000; [@bib31]). For coimmunoprecipitation of Gα~13~a with myc-tagged WT and mutant Arhgef11, the lysates were incubated with mouse anti-myc antibody (1:100; Santa Cruz Biotechnology, Inc.) overnight at 4°C. Protein-A--Sepharose was then added for 2 h at 4°C. Immunoprecipitates were immunoblotted with anti-Gα~13~ (1:1,000) and anti-myc (1:1,000; Fitzgerald) antibodies to detect the presence of Gα~13~a and the myc-tagged proteins. Gα~13~ antibody was provided by D. Manning (University of Philadelphia, Philadelphia, PA).

Whole-mount immunostaining
--------------------------

Embryos were fixed at appropriate stages in 4% PFA/PBS/4% sucrose at 4°C overnight. For F-actin staining, Alexa Fluor 546 phalloidin (1:100; Invitrogen) was used as described previously ([@bib27]). In addition, the following primary antibodies were used: anti--E-cadherin (1:1,000; [@bib5]), anti--α-tubulin (DM1A, 1:300; EMD), and anti--α-catenin (1:250; Sigma-Aldrich). Embryos were then mounted in 75% glycerol in PBS for analysis by microscopy.

Quantification of cell shape and alignment
------------------------------------------

Confocal images of EVL cells in Phalloidin-stained embryos were collected using a 20×/0.8 NA objective lens (Carl Zeiss, Inc.). LWRs (a ratio of the longest to shortest axis of the cell) and the angle of the long axis of the cells relative to a line parallel to the EVL margin were determined using Object-Image software. The angle of the long cell axes relative to the EVL margin was plotted in a half-Rose diagram (Vector Rose; PAZ software).

Cell scattering assays in vivo
------------------------------

At the 256-cell stage, a single cell at the animal pole was injected with 0.5% rhodamine-dextran ([@bib56]). Embryos were mounted on bridged slides filled with 2% methylcellulose, incubated at 28°C, and photographed every hour for 3 h to monitor the scattering of the labeled cells. To measure cell scattering, we exported the images to Object-Image. The exterior-most outlines of the labeled cells were marked and the areas encompassing the dispersed cells were calculated.

Microscopy
----------

Live embryos for still photography were mounted in 1.5--2% methylcellulose at 28.5°C, whereas fixed embryos were mounted in 75% glycerol/PBS. Embryos were photographed using 5--20× objectives on an Axiophot2 microscope or a Stereomicroscope (Stereo Discovery V12) equipped with an Axiocam digital camera (all from Carl Zeiss, Inc.). Axiovision software was used to capture the images. Confocal images were collected on a laser scanning inverted microscope (LSM 510; Carl Zeiss, Inc.) using a 40×/1.30 NA oil objective with zoom 2 or a 20×/0.8 NA objective using the LSM 510 software. The acquired images were exported and edited using Photoshop (Adobe), and then compiled in Illustrator software (Adobe).

Statistical analysis
--------------------

Data are presented as the mean ± SEM. Statistical analyses were performed using unpaired Student\'s *t* tests with 2 tails, unequal variance.

Online supplemental material
----------------------------

Fig. S1 shows that the distribution of β-catenin and α-catenin is not changed in cells expressing Gα~13~a. Fig. S2 shows that Gα~13~a overexpression does not promote cell proliferation. Fig. S3 shows the microtubules in WT control embryos and embryos overexpressing Gα~13~a revealed by anti--α-tubulin staining. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200805148/DC1>.
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